Use of receptor antagonist in elucidating the mechanism of action of TRH in GH3 cells.
Drummond
A H
AH
Department of Pharmacology, School of Pharmacy, University of London, England.
Hughes
P J
PJ
Ruiz-Larrea
F
F
Joels
L A
LA
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology; D001569:Benzodiazepines; D002460:Cell Line; D007295:Inositol Phosphates / Q000378:metabolism; D010911:Pituitary Neoplasms; D017981:Receptors, Neurotransmitter / Q000187:drug effects / Q000502:physiology*; D018025:Receptors, Thyrotropin-Releasing Hormone; D015290:Second Messenger Systems; D013973:Thyrotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000502:physiology*
D014151:Anti-Anxiety Agents; D007295:Inositol Phosphates; D017981:Receptors, Neurotransmitter; D018025:Receptors, Thyrotropin-Releasing Hormone; D001569:Benzodiazepines; D013973:Thyrotropin-Releasing Hormone